GSK Investigational Site

Arhus C 8000

0 studies enrolling now · 1 studies all time

What they study most

Diabetes Mellitus, Type 1

Studies at this site

• Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1 — Completed